Don't miss important news
Sign up for a digest of the most important news every month.
Latest News
People who have PSC live with a higher risk of developing bile duct cancer (also known as cholangiocarcinoma, or CCA). Although the risk of developing it is low, the worry it causes is huge. CCA is difficult to detect because it mimics PSC and we do not yet have the tools to detect it early, and we don’t know which PSC patients are at highest risk of developing it. This is important, because if it is picked up early before symptoms appear, treatments have the best chance of success.
Martine Walmsley shares project updates and future goals from the 2026 Prague members’ meeting.
Medway NHS Foundation Trust becomes the 20th UK service to achieve IQILS accreditation.
New research explores a potential link between Epstein-Barr virus and primary sclerosing cholangitis.
100 samples collected: DNA methylation study advances early cancer detection in PSC.
PSC Support recently attended the British Association for the Study of the Liver (BASL) Immune Special Interest Group (SIG) meeting. This meeting highlighted important progress in research and care, and on new medications for autoimmune liver diseases.
PSC research on genetic changes in bile ducts is now in its key analytical phase to unlock understanding.
New blood-based markers could help predict primary sclerosing cholangitis progression and cancer risk.
New PSC-IBD research from Dr Chandni Radia suggests bowel cancer risk may be lower than previously thought, helping us build evidence to tailor future colonoscopy guidelines.